RecruitingNCT06402695

Observational Study on GEP-and Pulm-NET Treated at FPG

Observational Study on Clinical, Laboratory, Anatomopathological and Molecular Characteristics and Their Prognostic and Predictive Value in Patients With Neuroendocrine Tumors of the Gastroenteropancreatic Tract and Pulmonary Treated at Fondazione Policlinico Agostino Gemelli (FPG)-IRCCS


Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment

650 participants

Start Date

Sep 15, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Observational ambispective monocentric study on the clinical, laboratory, pathological and molecular characteristics of patients suffering from gastroenteropancreatic tract and pulmonary neuroendocrine tumors and their prognostic and predictive value.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • histological diagnosis of gastroenteropancreatic or pulmonary NET
  • age ≥ 18 years;
  • radiological evidence of resectable/locally advanced/metastatic disease;
  • signing of informed consent;
  • at least one visit following the first oncological visit.

Exclusion Criteria3

  • absence of clinical data that allow adequate definition of survival (primary endpoint of the study);
  • absence of histological diagnosis;
  • failure to sign the informed consent.

Locations(1)

Fondazione Policlinico Universitario Agostino Gemelli - IRCCS

Rome, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06402695


Related Trials